Impact of Blood‑Based Biomarkers on Time to Treatment Initiation with Anti-Amyloid Therapies: A Retrospective Analysis Using the Optum Market Clarity Alzheimer’s Enriched Data
Copies of these presentations obtained through the QR code are for personal use only and may not be used without permission from CTAD and the authors of this presentation.